{
 "name": "Psilocybin in Florida: a dated timeline",
 "description": "Dated events in Florida's law, courts, research and enforcement on psilocybin mushrooms, each with its primary source.",
 "publisher": "Magic Mushrooms Miami",
 "url": "https://magicmushroomsmiami.com/florida-psilocybin-timeline",
 "license": "CC BY 4.0",
 "license_url": "https://creativecommons.org/licenses/by/4.0/",
 "updated": "2026-11-02",
 "record_count": 85,
 "source_note": "Each row is one dated event with the source it was checked against.",
 "records": [
  {
   "id": "csa-1970",
   "date": "1970-10-27",
   "category": "law",
   "event": "Congress enacts the Controlled Substances Act, which lists psilocybin and psilocyn in Schedule I, the federal category for drugs with a high potential for abuse and no currently accepted medical use in treatment.",
   "place": "United States",
   "source_title": "21 U.S. Code 812, Schedules of controlled substances (U.S. Code, GovInfo)",
   "source_url": "https://www.govinfo.gov/content/pkg/USCODE-2023-title21/html/USCODE-2023-title21-chap13-subchapI-partB-sec812.htm",
   "status": "happened"
  },
  {
   "id": "un-convention-1971",
   "date": "1971-02-21",
   "category": "law",
   "event": "The UN Convention on Psychotropic Substances is concluded. The U.S. Supreme Court later described it as a treaty signed by the United States and implemented by the Controlled Substances Act.",
   "place": "International",
   "source_title": "Gonzales v. O Centro, 546 U.S. 418 (2006), U.S. Reports",
   "source_url": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep546/usrep546418/usrep546418.pdf",
   "status": "happened"
  },
  {
   "id": "florida-chapter-893-1973",
   "date": "1973",
   "precision": "year",
   "category": "law",
   "event": "Florida enacts ch. 73-331. Section 3 of that law is the first entry in the history of section 893.03, the Florida drug schedules that today list psilocybin and psilocyn in Schedule I.",
   "place": "Florida",
   "source_title": "Florida Statutes 893.03, history note (Florida Senate, 2026)",
   "source_url": "https://www.flsenate.gov/Laws/Statutes/2026/893.03",
   "status": "happened"
  },
  {
   "id": "fiske-1978",
   "date": "1978-12-21",
   "category": "courts",
   "event": "In Fiske v. State, the Florida Supreme Court, 4-3, reverses a Collier County conviction for possessing wild mushrooms that contained psilocybin, because the statute gave that defendant no fair warning. It also says there is \"no vagueness problem with the statute on its face.\"",
   "place": "Florida",
   "source_title": "Fiske v. State, 366 So. 2d 423 (Fla. 1978), Justia",
   "source_url": "https://law.justia.com/cases/florida/supreme-court/1978/50796-0.html",
   "status": "happened"
  },
  {
   "id": "kansas-fiske-1985",
   "date": "1985-08-15",
   "category": "courts",
   "event": "The Kansas Court of Appeals holds that Kansas's psilocybin statutes, which don't name mushrooms, aren't unconstitutionally vague. It distinguishes Fiske because the Florida case had no evidence the defendant knew the mushrooms contained psilocybin (10 Kan. App. 2d 569, 704 P.2d 1012).",
   "place": "Kansas",
   "source_title": "10 Kan. App. 2d 569, 704 P.2d 1012 (Kan. Ct. App. 1985), Caselaw Access Project",
   "source_url": "https://static.case.law/kan-app-2d/10/cases/0569-01.json",
   "status": "happened"
  },
  {
   "id": "miami-drug-court-1989",
   "date": "1989",
   "precision": "year",
   "category": "policy",
   "event": "In the summer of 1989, an administrative order of the chief judge of Florida's 11th Judicial Circuit starts Miami-Dade's drug court. The National Institute of Justice later wrote that the order \"set the first drug court in motion.\"",
   "place": "Miami-Dade County",
   "source_title": "The Drug Court Movement, NIJ Update, National Institute of Justice (September 1995)",
   "source_url": "https://www.ojp.gov/txtfiles/drgctmov.txt",
   "status": "happened"
  },
  {
   "id": "rfra-1993",
   "date": "1993-11-16",
   "category": "law",
   "event": "Congress enacts the Religious Freedom Restoration Act, which bars government from substantially burdening a person's exercise of religion, even through a rule of general applicability, unless it shows the burden furthers a compelling interest by the least restrictive means.",
   "place": "United States",
   "source_title": "Public Law 103-141, Religious Freedom Restoration Act of 1993, 107 Stat. 1488 (GovInfo)",
   "source_url": "https://www.govinfo.gov/content/pkg/STATUTE-107/pdf/STATUTE-107-Pg1488.pdf",
   "status": "happened"
  },
  {
   "id": "indiana-fiske-1995",
   "date": "1995-06-22",
   "category": "courts",
   "event": "The Indiana Court of Appeals distinguishes Fiske, noting that Indiana's statute requires proof that the defendant knew what he had, while in Fiske there was no evidence the defendant knew he possessed illegal mushrooms (652 N.E.2d 89).",
   "place": "Indiana",
   "source_title": "652 N.E.2d 89 (Ind. Ct. App. 1995), Caselaw Access Project",
   "source_url": "https://static.case.law/ne2d/652/cases/0089-01.json",
   "status": "happened"
  },
  {
   "id": "fourth-dca-fiske-1996-09",
   "date": "1996-09-18",
   "category": "courts",
   "event": "Florida's Fourth District Court of Appeal decides an appeal in a one-line opinion, \"Affirmed based on the authority of Fiske v. State,\" that states no facts (679 So. 2d 363). The reported caption lists the State as appellant, but the attorney listing names the Public Defender as counsel for the appellant, so which side appealed is unclear.",
   "place": "Florida",
   "source_title": "679 So. 2d 363 (Fla. 4th DCA 1996), Caselaw Access Project",
   "source_url": "https://static.case.law/so2d/679/cases/0363-02.json",
   "status": "happened"
  },
  {
   "id": "fourth-dca-fiske-1996-12",
   "date": "1996-12-04",
   "category": "courts",
   "event": "The Fourth District again affirms in a one-line opinion that cites only Fiske and states no facts (683 So. 2d 657). Its caption and attorney listing conflict in the same way about which side appealed.",
   "place": "Florida",
   "source_title": "683 So. 2d 657 (Fla. 4th DCA 1996), Caselaw Access Project",
   "source_url": "https://static.case.law/so2d/683/cases/0657-01.json",
   "status": "happened"
  },
  {
   "id": "boerne-1997",
   "date": "1997-06-25",
   "category": "courts",
   "event": "In City of Boerne v. Flores, the U.S. Supreme Court holds that the federal RFRA exceeds Congress's power under the Fourteenth Amendment as applied to the states, so that law doesn't limit state laws.",
   "place": "United States",
   "source_title": "City of Boerne v. Flores, 521 U.S. 507 (1997), U.S. Reports (Library of Congress)",
   "source_url": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep521/usrep521507/usrep521507.pdf",
   "status": "happened"
  },
  {
   "id": "iowa-fiske-1997",
   "date": "1997-06-18",
   "category": "courts",
   "event": "The Iowa Supreme Court calls Fiske \"non-persuasive\" where a defendant's knowledge is established (564 N.W.2d 817).",
   "place": "Iowa",
   "source_title": "564 N.W.2d 817 (Iowa 1997), Caselaw Access Project",
   "source_url": "https://static.case.law/nw2d/564/cases/0817-01.json",
   "status": "happened"
  },
  {
   "id": "florida-rfra-1998",
   "date": "1998",
   "precision": "year",
   "category": "law",
   "event": "Florida enacts its own Religious Freedom Restoration Act (ch. 98-412), which says nothing in it \"shall be construed to circumvent the provisions of chapter 893,\" the state drug law.",
   "place": "Florida",
   "source_title": "Florida Statutes 761.05 (Florida Senate, 2026)",
   "source_url": "https://www.flsenate.gov/Laws/Statutes/2026/761.05",
   "status": "happened"
  },
  {
   "id": "florida-893-101-2002",
   "date": "2002",
   "precision": "year",
   "category": "law",
   "event": "Florida enacts section 893.101, which makes lack of knowledge of a drug's illicit nature an affirmative defense instead of an element the State must prove.",
   "place": "Florida",
   "source_title": "Florida Statutes 893.101 (Florida Senate, 2026)",
   "source_url": "https://www.flsenate.gov/Laws/Statutes/2026/893.101",
   "status": "happened"
  },
  {
   "id": "o-centro-2006",
   "date": "2006-02-21",
   "category": "courts",
   "event": "In Gonzales v. O Centro, the U.S. Supreme Court rules 8-0 that the federal government hadn't shown, at the preliminary injunction stage, a compelling interest in barring one church's sincere sacramental use of hoasca, a tea containing DMT.",
   "place": "United States",
   "source_title": "Gonzales v. O Centro, 546 U.S. 418 (2006), U.S. Reports",
   "source_url": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep546/usrep546418/usrep546418.pdf",
   "status": "happened"
  },
  {
   "id": "good-samaritan-2012",
   "date": "2012",
   "precision": "year",
   "category": "law",
   "event": "Florida creates its 911 Good Samaritan overdose law, section 893.21 (ch. 2012-36). As amended, it protects a person who seeks medical help for an overdose, and the person overdosing, from arrest, charge, prosecution or penalty for listed drug and paraphernalia possession offenses when the evidence was obtained because help was sought.",
   "place": "Florida",
   "source_title": "Florida Statutes 893.21 (Florida Senate, 2026)",
   "source_url": "https://www.flsenate.gov/Laws/Statutes/2026/893.21",
   "status": "happened"
  },
  {
   "id": "maps-miami-beach-2012",
   "date": "2012-01",
   "precision": "month",
   "category": "research",
   "event": "A MAPS-sponsored Phase 2 study of psilocybin-assisted psychotherapy for anxiety in people with stage IV melanoma lists a January 2012 start at Mount Sinai Comprehensive Cancer Center in Miami Beach. The registry shows it was withdrawn without enrolling anyone.",
   "place": "Miami-Dade County",
   "source_title": "ClinicalTrials.gov NCT00979693",
   "source_url": "https://clinicaltrials.gov/study/NCT00979693",
   "status": "happened"
  },
  {
   "id": "knowledge-defense-upheld-2012",
   "date": "2012-07-12",
   "category": "courts",
   "event": "The Florida Supreme Court upholds section 893.101, holding that the Legislature did not violate due process by making lack of knowledge an affirmative defense to chapter 893 offenses (96 So. 3d 412).",
   "place": "Florida",
   "source_title": "96 So. 3d 412 (Fla. 2012), Caselaw Access Project",
   "source_url": "https://static.case.law/so3d/96/cases/0412-01.json",
   "status": "happened"
  },
  {
   "id": "idea-exchange-2016",
   "date": "2016-12-01",
   "category": "policy",
   "event": "The University of Miami's IDEA Exchange opens, which the university describes as the first pilot syringe services program in Florida.",
   "place": "Miami-Dade County",
   "source_title": "About Us, IDEA Exchange, University of Miami Miller School of Medicine",
   "source_url": "https://med.miami.edu/community-outreach/idea/about-us",
   "status": "happened"
  },
  {
   "id": "soul-quest-petition-2017",
   "date": "2017-08-21",
   "category": "policy",
   "event": "Soul Quest Church of Mother Earth, an Orlando church that uses ayahuasca (a DMT tea, not psilocybin), petitions the DEA for a religious exemption from the Controlled Substances Act.",
   "place": "Orlando, Florida",
   "source_title": "Soul Quest Church of Mother Earth v. DEA, No. 22-11052 (11th Cir. 2024)",
   "source_url": "https://media.ca11.uscourts.gov/opinions/unpub/files/202211052.pdf",
   "status": "happened"
  },
  {
   "id": "breakthrough-trd-2018",
   "date": "2018",
   "precision": "year",
   "category": "research",
   "event": "FDA grants Breakthrough Therapy designation to psilocybin for treatment-resistant depression (COMPASS Pathways). FDA says such a designation isn't a finding of safety or effectiveness.",
   "place": "United States",
   "source_title": "FDA notice of public hearing on psychedelic drugs, 91 FR 43095 (July 14, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-07-14/pdf/2026-14155.pdf",
   "status": "happened"
  },
  {
   "id": "breakthrough-mdd-2019",
   "date": "2019-11-22",
   "category": "research",
   "event": "Usona Institute announces that FDA has granted Breakthrough Therapy designation to its psilocybin program for major depressive disorder.",
   "place": "United States",
   "source_title": "FDA grants Breakthrough Therapy Designation to Usona Institute's psilocybin program for major depressive disorder, Usona Institute (November 22, 2019)",
   "source_url": "https://www.usonainstitute.org/updates/fda-grants-breakthrough-therapy-designation-to-usona-institutes-psilocybin-program-for-major-depressive-disorder",
   "status": "happened"
  },
  {
   "id": "driver-license-2019",
   "date": "2019-10-01",
   "category": "law",
   "event": "Florida's ch. 2019-167 takes effect. For adults convicted of drug possession or sale, it replaces a 1-year driver license revocation with a 6-month suspension; both versions add \"or until\" the person is evaluated and completes any required treatment.",
   "place": "Florida",
   "source_title": "Laws of Florida, ch. 2019-167 (Florida Department of State)",
   "source_url": "https://laws.flrules.org/2019/167",
   "status": "happened"
  },
  {
   "id": "oregon-measure-109-2020",
   "date": "2020",
   "precision": "year",
   "category": "law",
   "event": "Oregon voters approve Measure 109, the Oregon Psilocybin Services Act, which licenses supervised psilocybin sessions for adults 21 and over at service centers.",
   "place": "Oregon",
   "source_title": "Oregon Revised Statutes chapter 475A (Oregon Legislature)",
   "source_url": "https://www.oregonlegislature.gov/bills_laws/ors/ors475A.html",
   "status": "happened"
  },
  {
   "id": "usona-phase2-2020",
   "date": "2020-01-23",
   "category": "research",
   "event": "Usona Institute's Phase 2 psilocybin trial for major depressive disorder starts, with a site at Segal Trials in Lauderhill.",
   "place": "Broward County",
   "source_title": "ClinicalTrials.gov NCT03866174",
   "source_url": "https://clinicaltrials.gov/study/NCT03866174",
   "status": "happened"
  },
  {
   "id": "um-tassili-2020",
   "date": "2020-02-17",
   "category": "research",
   "event": "University of Miami researchers announce $1.624 million from Tassili Life Sciences to study a CBD and psilocybin combination for mild traumatic brain injury and PTSD, starting with animal research.",
   "place": "Miami-Dade County",
   "source_title": "InventUM, University of Miami Miller School of Medicine (February 17, 2020)",
   "source_url": "https://news.med.miami.edu/um-to-study-if-cbd-combined-with-a-psychedelic-drug-can-treat-combined-traumatic-brain-injury-and-ptsd/",
   "status": "happened"
  },
  {
   "id": "hb-549-filed-2021",
   "date": "2021-01-28",
   "category": "policy",
   "event": "Rep. Michael Grieco files HB 549, the \"Florida Psilocybin Mental Health Care Act,\" which would have created a state-licensed psilocybin services program for adults 21 and over.",
   "place": "Florida",
   "source_title": "HB 549 (2021), Use of Psilocybin for Mental Health Treatment, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2021/549",
   "status": "happened"
  },
  {
   "id": "soul-quest-denied-2021",
   "date": "2021-04-16",
   "category": "policy",
   "event": "The DEA denies Soul Quest's religious exemption petition, saying the church hadn't shown that its members' beliefs were sincerely held or that its ayahuasca use was religious exercise, and citing compelling interests in public safety and preventing diversion.",
   "place": "Orlando, Florida",
   "source_title": "Soul Quest Church of Mother Earth v. DEA, No. 22-11052 (11th Cir. 2024)",
   "source_url": "https://media.ca11.uscourts.gov/opinions/unpub/files/202211052.pdf",
   "status": "happened"
  },
  {
   "id": "hb-549-died-2021",
   "date": "2021-04-30",
   "category": "policy",
   "event": "HB 549 dies in the House Professions & Public Health Subcommittee, its first committee, without a hearing. It had no Senate companion.",
   "place": "Florida",
   "source_title": "HB 549 (2021), Use of Psilocybin for Mental Health Treatment, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2021/549",
   "status": "happened"
  },
  {
   "id": "hb-193-sb-348-filed-2021",
   "date": "2021-09-24",
   "category": "policy",
   "event": "Rep. Michael Grieco files HB 193 and Sen. Lauren Book files SB 348, which would have had the Department of Health study MDMA, psilocybin and ketamine for depression, PTSD and other conditions.",
   "place": "Florida",
   "source_title": "SB 348 (2022), Using Alternative Therapies to Treat Mental Health and Other Medical Conditions, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2022/348",
   "status": "happened"
  },
  {
   "id": "soul-quest-district-2022",
   "date": "2022-03-04",
   "category": "courts",
   "event": "A federal court in Orlando dismisses Soul Quest's lawsuit against the DEA for lack of jurisdiction, because review of a DEA final decision belongs in a federal court of appeals.",
   "place": "Orlando, Florida",
   "source_title": "Order, No. 6:20-cv-701 (M.D. Fla. March 4, 2022), CourtListener",
   "source_url": "https://storage.courtlistener.com/recap/gov.uscourts.flmd.376612/gov.uscourts.flmd.376612.74.0.pdf",
   "status": "happened"
  },
  {
   "id": "hb-193-sb-348-died-2022",
   "date": "2022-03-14",
   "category": "policy",
   "event": "HB 193 and SB 348 die in their first committees without a hearing.",
   "place": "Florida",
   "source_title": "HB 193 (2022), Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2022/193",
   "status": "happened"
  },
  {
   "id": "uf-binge-eating-2022",
   "date": "2022-03-16",
   "category": "research",
   "event": "TRYP Therapeutics starts a single-site, open-label Phase 2a study of psilocybin (TRP-8802) with psychotherapy for binge eating disorder at the University of Florida in Gainesville; it enrolled 5 people.",
   "place": "Gainesville, Florida",
   "source_title": "ClinicalTrials.gov NCT05035927",
   "source_url": "https://clinicaltrials.gov/study/NCT05035927",
   "status": "happened"
  },
  {
   "id": "colorado-prop-122-2022",
   "date": "2022-11-08",
   "category": "law",
   "event": "Colorado voters pass Proposition 122, 1,296,992 to 1,121,124, creating a regulated natural medicine access program for supervised care for adults 21 and over.",
   "place": "Colorado",
   "source_title": "Proposition 122, 2022 general election official results, Colorado Secretary of State",
   "source_url": "https://historicalelectiondata.coloradosos.gov/contest/25863",
   "status": "happened"
  },
  {
   "id": "fdacs-tampa-amanita-2022",
   "date": "2022-12-07",
   "category": "enforcement",
   "event": "Florida's Department of Agriculture and Consumer Services visits a Tampa hemp dispensary and places a stop-sale on its Amanita muscaria products, having found a \"poisonous or deleterious substance\" under state food-safety law, the owner wrote, as reported by Miami New Times. Amanita muscaria isn't listed in Florida's drug schedules.",
   "place": "Tampa, Florida",
   "source_title": "Florida's First \"Magic Mushroom\" Dispensary Halts Sales, Miami New Times (January 17, 2023)",
   "source_url": "https://www.miaminewtimes.com/news/floridas-first-magic-mushroom-dispensary-halts-sales-16122033",
   "status": "happened"
  },
  {
   "id": "comp005-2023",
   "date": "2023-01-24",
   "category": "research",
   "event": "COMPASS Pathways starts COMP005, a Phase 3 trial of its psilocybin drug COMP360 for treatment-resistant depression, with sites listed in Orlando and Tampa.",
   "place": "Florida",
   "source_title": "ClinicalTrials.gov NCT05624268",
   "source_url": "https://clinicaltrials.gov/study/NCT05624268",
   "status": "happened"
  },
  {
   "id": "comp104-2023",
   "date": "2023-01-30",
   "category": "research",
   "event": "COMPASS Pathways starts a Phase 2 COMP360 trial for recurrent major depressive disorder with a site in Jacksonville.",
   "place": "Jacksonville, Florida",
   "source_title": "ClinicalTrials.gov NCT05733546",
   "source_url": "https://clinicaltrials.gov/study/NCT05733546",
   "status": "happened"
  },
  {
   "id": "comp006-2023",
   "date": "2023-02-14",
   "category": "research",
   "event": "COMPASS Pathways starts COMP006, a Phase 3 COMP360 trial for treatment-resistant depression, with Florida sites including Miami, Miami Lakes, Lauderhill and West Palm Beach.",
   "place": "Miami-Dade County",
   "source_title": "ClinicalTrials.gov NCT05711940",
   "source_url": "https://clinicaltrials.gov/study/NCT05711940",
   "status": "happened"
  },
  {
   "id": "fdacs-five-businesses-2023",
   "date": "2023-05-31",
   "category": "enforcement",
   "event": "A KFF Health News report published by WUSF says Florida regulators have cited five businesses, in Daytona Beach, Largo, Plant City, Tallahassee and Tamarac, over Amanita muscaria products since early February, according to state agriculture department records.",
   "place": "Florida",
   "source_title": "Mood-altering mushroom sales bloom despite Florida and federal safety concerns, WUSF (May 31, 2023)",
   "source_url": "https://www.wusf.org/health-news-florida/2023-05-31/mood-altering-mushroom-sales-bloom-despite-florida-and-federal-safety-concerns",
   "status": "happened"
  },
  {
   "id": "fentanyl-strips-2023",
   "date": "2023-07-01",
   "category": "law",
   "event": "Testing products used solely to detect fentanyl or listed fentanyl-related substances, such as fentanyl test strips, stop counting as drug paraphernalia in Florida under CS/SB 164 (ch. 2023-297), approved June 27, 2023. Products that measure quantity, weight or potency aren't covered.",
   "place": "Florida",
   "source_title": "SB 164 (2023), Controlled Substance Testing, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2023/164",
   "status": "happened"
  },
  {
   "id": "fdacs-subpoena-suit-2023",
   "date": "2023-08-21",
   "category": "enforcement",
   "event": "The News Service of Florida reports that the state agriculture department sued a Tallahassee business in Leon County circuit court to enforce a subpoena about Amanita muscaria products, calling the mushroom an \"unsafe food or food additive.\"",
   "place": "Tallahassee, Florida",
   "source_title": "News Service of Florida report via WMNF (August 21, 2023)",
   "source_url": "https://www.wmnf.org/florida-sues-a-tallahassee-business-over-hallucinogenic-mushroom-information/",
   "status": "happened"
  },
  {
   "id": "martin-county-store-2023",
   "date": "2023-09-01",
   "category": "enforcement",
   "event": "The Martin County Sheriff's Office arrests an employee of a Jensen Beach mall store accused of selling psilocybin mushrooms from the store after an undercover purchase, according to the Miami Herald.",
   "place": "Martin County",
   "source_title": "Miami Herald report via AOL (October 5, 2023)",
   "source_url": "https://www.aol.com/hallucinogenic-mushrooms-were-sold-florida-155959723.html",
   "status": "happened"
  },
  {
   "id": "usf-request-2023",
   "date": "2023-12-13",
   "category": "policy",
   "event": "Sen. Jay Collins requests $3,000,000 for a USF Health clinical trial of psilocybin for PTSD in veterans (Senate funding request 2851).",
   "place": "Florida",
   "source_title": "FY 2024-25 Local Funding Initiative Request 2851, Florida Senate",
   "source_url": "https://www.flsenate.gov/PublishedContent/Session/FiscalYear/FY2024-25/LocalFundingInitiativeRequests/FY2024-25_S2851.pdf",
   "status": "happened"
  },
  {
   "id": "soul-quest-11th-2023",
   "date": "2023-12-18",
   "category": "courts",
   "event": "The Eleventh Circuit, over a dissent, affirms dismissal of Soul Quest's suit, holding that challenges to the DEA's denial had to go straight to a court of appeals under 21 U.S.C. 877.",
   "place": "Florida",
   "source_title": "Soul Quest Church of Mother Earth v. Attorney General, No. 22-11072 (11th Cir. 2023)",
   "source_url": "https://media.ca11.uscourts.gov/opinions/pub/files/202211072.pdf",
   "status": "happened"
  },
  {
   "id": "dea-spores-letter-2024",
   "date": "2024-01-02",
   "category": "policy",
   "event": "A DEA letter says mushroom spores that contain no psilocybin or psilocin are not controlled under federal law, but material that does contain them is.",
   "place": "United States",
   "source_title": "DEA letter on psilocybin mushroom spores (January 2, 2024), DocumentCloud",
   "source_url": "https://s3.documentcloud.org/documents/24253679/dea-psilocybin-spores-letter.pdf",
   "status": "happened"
  },
  {
   "id": "senate-budget-usf-2024",
   "date": "2024-02",
   "precision": "month",
   "category": "policy",
   "event": "The Florida Senate's budget bill carries $650,000 for the USF psilocybin study in veterans with PTSD, after an amendment cut it from $1,000,000.",
   "place": "Florida",
   "source_title": "SB 2500 (2024), engrossed text, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2024/2500/BillText/e1/PDF",
   "status": "happened"
  },
  {
   "id": "soul-quest-untimely-2024",
   "date": "2024-02-27",
   "category": "courts",
   "event": "The Eleventh Circuit dismisses Soul Quest's petition for review of the DEA denial as untimely, about 10 months late, without reaching the merits.",
   "place": "Florida",
   "source_title": "Soul Quest Church of Mother Earth v. DEA, No. 22-11052 (11th Cir. 2024)",
   "source_url": "https://media.ca11.uscourts.gov/opinions/unpub/files/202211052.pdf",
   "status": "happened"
  },
  {
   "id": "cyb003-breakthrough-2024",
   "date": "2024-03-13",
   "category": "research",
   "event": "Cybin announces that FDA has granted Breakthrough Therapy designation to CYB003, its deuterated psilocin drug candidate, which the company, now doing business as Helus Pharma, calls HLP003.",
   "place": "United States",
   "source_title": "Cybin Inc. (doing business as Helus Pharma), management's discussion and analysis, SEC filing (August 14, 2026)",
   "source_url": "https://www.sec.gov/Archives/edgar/data/1833141/000183314126000058/cybin-mdaxq1x27.htm",
   "status": "happened"
  },
  {
   "id": "usona-phase3-2024",
   "date": "2024-03-13",
   "category": "research",
   "event": "Usona Institute's Phase 3 psilocybin trial for major depressive disorder starts, with Florida sites in Jacksonville, Lauderhill and Orlando.",
   "place": "Florida",
   "source_title": "ClinicalTrials.gov NCT06308653",
   "source_url": "https://clinicaltrials.gov/study/NCT06308653",
   "status": "happened"
  },
  {
   "id": "gao-religious-2024",
   "date": "2024-05-30",
   "category": "policy",
   "event": "GAO reports that 24 petitioners sought DEA religious exemptions from fiscal year 2016 through January 2024 and none had been granted; of 6 psilocybin petitions, 3 were withdrawn and 3 were pending.",
   "place": "United States",
   "source_title": "GAO-24-106630, U.S. Government Accountability Office",
   "source_url": "https://www.gao.gov/products/gao-24-106630",
   "status": "happened"
  },
  {
   "id": "budget-no-psilocybin-2024",
   "date": "2024-06-12",
   "category": "policy",
   "event": "The Governor approves Florida's 2024-25 budget (ch. 2024-231). It contains no psilocybin funding; the Senate's USF study line didn't survive.",
   "place": "Florida",
   "source_title": "HB 5001 (2024), General Appropriations Act, enrolled text, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2024/5001/BillText/er/PDF",
   "status": "happened"
  },
  {
   "id": "diamond-shruumz-recall-2024",
   "date": "2024-06-27",
   "category": "enforcement",
   "event": "Diamond Shruumz chocolate bars, cones and gummies are recalled. FDA's outbreak page later listed 180 illnesses (118 involving Diamond Shruumz products), 6 of them in Florida, and FDA testing found psilocin, muscimol and other substances in some samples.",
   "place": "United States",
   "source_title": "FDA outbreak investigation: Diamond Shruumz-brand chocolate bars, cones and gummies",
   "source_url": "https://www.fda.gov/food/outbreaks-foodborne-illness/investigation-illnesses-diamond-shruumz-brand-chocolate-bars-cones-gummies-june-2024",
   "status": "happened"
  },
  {
   "id": "approach-start-2024",
   "date": "2024-12-17",
   "category": "research",
   "event": "Cybin starts APPROACH, a Phase 3 trial of CYB003 for major depressive disorder, with Florida sites including Miami, North Miami and Hollywood.",
   "place": "Miami-Dade County",
   "source_title": "ClinicalTrials.gov NCT06564818",
   "source_url": "https://clinicaltrials.gov/study/NCT06564818",
   "status": "happened"
  },
  {
   "id": "fda-amanita-2024",
   "date": "2024-12-18",
   "category": "policy",
   "event": "FDA says Amanita muscaria and its constituents muscimol, ibotenic acid and muscarine are not authorized in conventional food, and recommends people avoid foods containing them.",
   "place": "United States",
   "source_title": "FDA constituent update on Amanita muscaria in food (December 18, 2024)",
   "source_url": "https://www.fda.gov/food/hfp-constituent-updates/fda-alerts-industry-and-consumers-about-use-amanita-muscaria-or-its-constituents-food",
   "status": "happened"
  },
  {
   "id": "usf-request-2025",
   "date": "2025-02-18",
   "category": "policy",
   "event": "Sen. Jay Collins again requests $3,000,000 for a USF psilocybin trial in veterans with PTSD (Senate funding request 1393). The 2025-26 budget the Governor approved (ch. 2025-198) contains no psilocybin funding.",
   "place": "Florida",
   "source_title": "FY 2025-26 Local Funding Initiative Request 1393, Florida Senate",
   "source_url": "https://www.flsenate.gov/PublishedContent/Session/FiscalYear/FY2025-26/LocalFundingInitiativeRequests/FY2025-26_S1393.pdf",
   "status": "happened"
  },
  {
   "id": "colorado-first-sessions-2025",
   "date": "2025-06",
   "precision": "month",
   "category": "policy",
   "event": "The first psilocybin administration sessions begin at Colorado's licensed healing centers, according to the state's Department of Revenue.",
   "place": "Colorado",
   "source_title": "Annual Natural Medicine Implementation Report, Colorado Department of Revenue (February 2, 2026)",
   "source_url": "https://drive.google.com/file/d/1_81cioS5lMJvZBJgDpRudMlIZjDM3YDf/view",
   "status": "happened"
  },
  {
   "id": "new-mexico-act-2025",
   "date": "2025-06-20",
   "category": "law",
   "event": "New Mexico's Medical Psilocybin Act takes effect; the Department of Health says the program is set to be implemented by December 31, 2026.",
   "place": "New Mexico",
   "source_title": "Medical Psilocybin Program, New Mexico Department of Health",
   "source_url": "https://www.nmhealth.org/about/mcpp/mpp/",
   "status": "happened"
  },
  {
   "id": "miami-beach-apartment-2025",
   "date": "2025-06-25",
   "category": "enforcement",
   "event": "NBC 6 reports that Miami Beach police found suspected psilocybin mushrooms with cocaine, ketamine, fentanyl and other drugs in a Miami Beach apartment; a man was arrested on drug trafficking and child abuse charges.",
   "place": "Miami-Dade County",
   "source_title": "NBC 6 South Florida (June 25, 2025)",
   "source_url": "https://www.nbcmiami.com/news/local/alleged-trafficker-kept-drug-stash-in-miami-beach-apartment-with-3-year-old-son-cops/3645778/",
   "status": "happened"
  },
  {
   "id": "spore-ban-2025",
   "date": "2025-07-01",
   "category": "law",
   "event": "Florida's section 500.75 takes effect, making it a first-degree misdemeanor to transport, import, sell, furnish or give away mushroom spores or mycelium that will produce psilocybin or psilocyn; possession isn't listed. It came from CS/CS/CS/SB 700 (ch. 2025-22), approved by the Governor May 15, 2025.",
   "place": "Florida",
   "source_title": "CS/CS/CS/SB 700 (2025), Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2025/700",
   "status": "happened"
  },
  {
   "id": "cyb003-extension-2025",
   "date": "2025-07-18",
   "category": "research",
   "event": "Cybin starts EXTEND, a long-term extension study of CYB003 open by invitation, with Florida sites including Hollywood and Lauderhill.",
   "place": "Broward County",
   "source_title": "ClinicalTrials.gov NCT06605105",
   "source_url": "https://clinicaltrials.gov/study/NCT06605105",
   "status": "happened"
  },
  {
   "id": "seven-oh-emergency-2025",
   "date": "2025-08-12",
   "category": "law",
   "event": "Florida's Attorney General issues emergency rule 2ER25-1, adding 7-hydroxymitragynine (7-OH), a kratom-derived compound, to Schedule I when concentrated above 1 percent by total weight.",
   "place": "Florida",
   "source_title": "Rule 2ER25-1, Florida Administrative Register",
   "source_url": "https://flrules.org/gateway/ruleNo.asp?id=2ER25-1",
   "status": "happened"
  },
  {
   "id": "operation-slow-n-go-2025",
   "date": "2025-11-04",
   "category": "enforcement",
   "event": "Florida's Attorney General announces Operation Slow N Go, led by the Palm Beach County Sheriff's Office and the Office of Statewide Prosecution, against a ring operating in Miami-Dade and six other Florida counties. The release says it uncovered trafficking in psilocybin among other drugs and lists 5 arrests and 23 charges, none naming psilocybin.",
   "place": "Florida",
   "source_title": "Attorney General press release (November 4, 2025)",
   "source_url": "https://www.myfloridalegal.com/newsrelease/attorney-general-james-uthmeier-announces-arrests-and-charges-massive-south-florida",
   "status": "happened"
  },
  {
   "id": "embrace-start-2025",
   "date": "2025-12-10",
   "category": "research",
   "event": "Cybin starts EMBRACE, a second Phase 3 trial of CYB003 for major depressive disorder, recruiting in Jacksonville, Maitland, Naples and Tampa.",
   "place": "Florida",
   "source_title": "ClinicalTrials.gov NCT06793397",
   "source_url": "https://clinicaltrials.gov/study/NCT06793397",
   "status": "happened"
  },
  {
   "id": "miami-smoke-shop-2026",
   "date": "2026-03-13",
   "category": "enforcement",
   "event": "NBC 6 reports that City of Miami police made an undercover purchase and served a SWAT search warrant at a Miami smoke shop, seizing suspected psilocybin edibles, psilocybin and suspected 7-OH; one man was arrested.",
   "place": "Miami-Dade County",
   "source_title": "NBC 6 South Florida (March 13, 2026)",
   "source_url": "https://www.nbcmiami.com/news/local/huge-drug-stash-found-after-undercover-miami-smoke-shop-swat-raid-police-say/3780719/",
   "status": "happened"
  },
  {
   "id": "okeechobee-stop-2026",
   "date": "2026-03-25",
   "category": "enforcement",
   "event": "WQCS reports that an Okeechobee County traffic stop near a music festival turned up dried mushrooms and mushroom chocolate; one person was charged with possession with intent to sell psilocybin, among other charges.",
   "place": "Okeechobee County",
   "source_title": "WQCS (March 25, 2026)",
   "source_url": "https://www.wqcs.org/wqcs-news/2026-03-25/traffic-stop-near-music-festival-leads-to-major-drug-bust-on-u-s-441",
   "status": "happened"
  },
  {
   "id": "oregon-out-of-state-2026",
   "date": "2026-03-31",
   "category": "policy",
   "event": "Oregon's quarterly psilocybin data for January 2025 through March 2026 add up to 2,114 client responses from people living elsewhere in the U.S. (repeat clients may be counted more than once).",
   "place": "Oregon",
   "source_title": "Psilocybin Data Archive, Oregon Health Authority",
   "source_url": "https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Psilocybin-Data-Archive.aspx",
   "status": "happened"
  },
  {
   "id": "priority-vouchers-2026",
   "date": "2026-04",
   "precision": "month",
   "category": "policy",
   "event": "FDA issues national priority vouchers to companies studying psilocybin for treatment-resistant depression and for major depressive disorder. FDA says a voucher isn't a determination of safety or effectiveness.",
   "place": "United States",
   "source_title": "FDA notice of public hearing on psychedelic drugs, 91 FR 43095 (July 14, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-07-14/pdf/2026-14155.pdf",
   "status": "happened"
  },
  {
   "id": "mmwr-shruumz-2026",
   "date": "2026-04-09",
   "category": "research",
   "event": "A CDC report counts 180 illnesses in 34 states, 73 hospitalizations and 2 deaths tied to Diamond Shruumz and other brands' mushroom chocolate products in 2024. FDA's own page counts 3 potentially associated deaths.",
   "place": "United States",
   "source_title": "CDC Morbidity and Mortality Weekly Report 75(13) (April 9, 2026)",
   "source_url": "https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a2.htm",
   "status": "happened"
  },
  {
   "id": "eo-14401-2026",
   "date": "2026-04-18",
   "category": "policy",
   "event": "Executive Order 14401 directs at least $50 million in existing funds, through ARPA-H, to support states that have enacted or are developing programs to advance psychedelic drugs for serious mental illness, and directs a prompt rescheduling review of any Schedule I product that completes Phase 3 trials for a serious mental health disorder.",
   "place": "United States",
   "source_title": "Executive Order 14401, 91 FR 21709 (April 22, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-04-22/pdf/2026-07907.pdf",
   "status": "happened"
  },
  {
   "id": "sb-432-2026",
   "date": "2026-06-16",
   "category": "law",
   "event": "The Governor approves CS/SB 432 (ch. 2026-148). Its section 3 rewrites the part of Florida's Schedule I that lists psilocybin and psilocyn, to exempt FDA-approved xylazine animal drug products used as approved. Psilocybin and psilocyn stay listed, unchanged.",
   "place": "Florida",
   "source_title": "CS/SB 432 (2026), Intoxicating Substances, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2026/432",
   "status": "happened"
  },
  {
   "id": "seven-oh-expansion-2026",
   "date": "2026-06-22",
   "category": "law",
   "event": "Florida's Attorney General signs an emergency rule, effective immediately, expanding Schedule I control to compounds related to concentrated 7-OH.",
   "place": "Florida",
   "source_title": "Attorney General press release (June 22, 2026)",
   "source_url": "https://www.myfloridalegal.com/newsrelease/attorney-general-james-uthmeier-signs-emergency-rule-immediately-scheduling-dangerous-7",
   "status": "happened"
  },
  {
   "id": "xylazine-strips-2026",
   "date": "2026-07-01",
   "category": "law",
   "event": "Testing products used solely to detect xylazine join the fentanyl test-strip exclusion from Florida's definition of drug paraphernalia under CS/HB 477 (ch. 2026-157), approved June 16, 2026. Products that measure quantity, weight or potency still aren't excluded.",
   "place": "Florida",
   "source_title": "HB 477 (2026), Drug Paraphernalia, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Bill/2026/477",
   "status": "happened"
  },
  {
   "id": "fda-guidance-2026",
   "date": "2026-07-14",
   "category": "policy",
   "event": "FDA publishes its final guidance \"Psychedelic Drugs: Considerations for Clinical Investigations,\" which gives general considerations for sponsors running clinical trials of psychedelic drugs.",
   "place": "United States",
   "source_title": "Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability, 91 FR 43101 (July 14, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-07-14/pdf/2026-14158.pdf",
   "status": "happened"
  },
  {
   "id": "redefine-start-2026",
   "date": "2026-09",
   "precision": "month",
   "category": "research",
   "event": "ClinicalTrials.gov lists September 2026 as the estimated start of COMPASS Pathways' Redefine study, a Phase 2/3 trial of COMP360 for PTSD, and shows it recruiting at sites in Miami and Orlando.",
   "place": "Miami-Dade County",
   "source_title": "ClinicalTrials.gov NCT07570654",
   "source_url": "https://clinicaltrials.gov/study/NCT07570654",
   "status": "happened"
  },
  {
   "id": "dea-tryptamines-2026",
   "date": "2026-09-23",
   "category": "policy",
   "event": "DEA proposes placing five tryptamine hallucinogens, including 4-OH-DiPT and 5-MeO-DET, in Schedule I; comments closed October 23, 2026. The proposal doesn't cover psilocybin, and Florida's Schedule I already lists four of the five by name.",
   "place": "United States",
   "source_title": "Proposed rule, 91 FR 60338 (September 23, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-23/pdf/2026-19400.pdf",
   "status": "happened"
  },
  {
   "id": "singularism-2026",
   "date": "2026-10-05",
   "category": "courts",
   "event": "The Tenth Circuit orders a federal trial court to vacate its injunction against Utah's criminal prosecution of the founder of Singularism, a religion whose ceremony includes psilocybin. It holds that the trial court should have abstained and erred in finding a likely First Amendment violation.",
   "place": "Utah",
   "source_title": "Opinion in No. 25-4115 (10th Cir. October 5, 2026), court filing via Justia",
   "source_url": "https://cases.justia.com/federal/appellate-courts/ca10/25-4115/25-4115-2026-10-05.pdf",
   "status": "happened"
  },
  {
   "id": "ibogaine-rfi-2026",
   "date": "2026-10-06",
   "category": "policy",
   "event": "FDA asks for public comment on approaches it is considering for early-phase ibogaine trials, citing heart rhythm risks. HHS is funding ibogaine research, and the first federally supported trials are expected to study opioid use disorder and PTSD.",
   "place": "United States",
   "source_title": "Request for information, 91 FR 63563 (October 6, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-10-06/pdf/2026-20427.pdf",
   "status": "happened"
  },
  {
   "id": "approach-complete-2026",
   "date": "2026-10-23",
   "category": "research",
   "event": "Cybin's APPROACH Phase 3 trial of CYB003, whose sites included Miami, North Miami and Hollywood, is completed, according to ClinicalTrials.gov; no results had been posted to the registry as of November 2, 2026.",
   "place": "Miami-Dade County",
   "source_title": "ClinicalTrials.gov NCT06564818",
   "source_url": "https://clinicaltrials.gov/study/NCT06564818",
   "status": "happened"
  },
  {
   "id": "colorado-healing-centers-2026",
   "date": "2026-10-30",
   "category": "policy",
   "event": "Colorado's Natural Medicine Division lists 47 approved healing center licenses as of this date: 12 standard and 35 micro.",
   "place": "Colorado",
   "source_title": "Natural Medicine Division home page, Colorado Department of Revenue",
   "source_url": "https://nmd.colorado.gov/home",
   "status": "happened"
  },
  {
   "id": "florida-ballot-2026",
   "date": "2026-11-03",
   "category": "policy",
   "event": "Scheduled: Florida's general election is set for this date. The statewide ballot carries three proposed constitutional amendments, all placed there by the Legislature; none concerns psilocybin or any other drug.",
   "place": "Florida",
   "source_title": "Constitutional amendments and initiatives, 2026 general election, Florida Division of Elections",
   "source_url": "https://constitutionalinitiatives.dos.fl.gov/?ElecYear=2026&CanType=&ElecType=GEN",
   "status": "scheduled"
  },
  {
   "id": "colorado-rules-hearing-2026",
   "date": "2026-11-04",
   "category": "policy",
   "event": "Scheduled: Colorado's Natural Medicine Division plans a final rulemaking hearing on natural medicine rules; written comments on its rulemaking to carry out HB26-1325 are also due November 4.",
   "place": "Colorado",
   "source_title": "Rulemaking, Colorado Natural Medicine Division",
   "source_url": "https://nmd.colorado.gov/rulemaking",
   "status": "scheduled"
  },
  {
   "id": "florida-organization-session-2026",
   "date": "2026-11-17",
   "category": "policy",
   "event": "Scheduled: The Florida Senate is set to convene for its organization session, 14 days after the general election, for the exclusive purpose of organization and selection of officers.",
   "place": "Florida",
   "source_title": "2026-2027 Interim Committee Meeting Schedule, Florida Senate (August 3, 2026)",
   "source_url": "https://www.flsenate.gov/PublishedContent/Offices/President/2026-2027_Interim_Committee_Meeting_Schedule_.pdf",
   "status": "scheduled"
  },
  {
   "id": "ibogaine-comments-close-2026",
   "date": "2026-11-20",
   "category": "policy",
   "event": "Scheduled: Public comments are due on FDA's request for information on ibogaine trial design.",
   "place": "United States",
   "source_title": "Request for information, 91 FR 63563 (October 6, 2026)",
   "source_url": "https://www.govinfo.gov/content/pkg/FR-2026-10-06/pdf/2026-20427.pdf",
   "status": "scheduled"
  },
  {
   "id": "new-mexico-target-2026",
   "date": "2026-12-31",
   "category": "policy",
   "event": "Scheduled: New Mexico's Department of Health says its medical psilocybin program is set to be implemented by this date; the Medical Psilocybin Act's legal deadline is December 31, 2027.",
   "place": "New Mexico",
   "source_title": "Medical Psilocybin Program, New Mexico Department of Health",
   "source_url": "https://www.nmhealth.org/about/mcpp/mpp/",
   "status": "scheduled"
  },
  {
   "id": "florida-2027-session",
   "date": "2027-03-02",
   "category": "policy",
   "event": "Scheduled: Florida's 2027 regular session is set to convene; noon that day is the Senate's deadline for filing bills, and April 30, 2027 is set as the session's last day.",
   "place": "Florida",
   "source_title": "2027 Regular Session Dates, Florida Senate",
   "source_url": "https://www.flsenate.gov/Session/Calendar/2027/Session%20Dates%202026-08-05%20084118.PDF",
   "status": "scheduled"
  }
 ]
}